Clinical Trials · NCT02749825
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- Pharmatech
- Enrollment
- 41
- Start date
- Sep 2002
- Locations
- 11 sites, United States
- Primary endpoint
- Maintenance of serum testosterone at or below castration level (50ng/dL)